Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Midatech appoints Jim Phillips CEO

This article was originally published in Scrip

Executive Summary

Abingdon, UK-based Midatech, a manufacturer of biocompatible gold nanoparticles (GNPs) with applications across several industries (including therapeutics, diagnostics and medical imaging) has named Dr Jim Phillips chief executive officer. Dr Phillips joins the company from UK consumer healthcare firm Healthcare Brands International, where he has been CEO since 2010. Founded in 2000, privately-held Midatech has a pipeline of product candidates in clinical and preclinical development for the treatment of diabetes and a variety of cancers.





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts